Meta-analysis of human and mouse ALS astrocytes reveals multi-omic signatures of inflammatory reactive states

  1. Rickie Patani1,2,3
  1. 1Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London WC1N 3BG, United Kingdom;
  2. 2The Francis Crick Institute, London NW1 1AT, United Kingdom;
  3. 3National Hospital for Neurology and Neurosurgery, University College London NHS Foundation Trust, London WC1N 3BG, United Kingdom;
  4. 4Department of Zoology, Faculty of Science, Alexandria University, Alexandria 21511, Egypt;
  5. 5UCL Genetics Institute, University College London, London WC1E 6BT, United Kingdom;
  6. 6Okinawa Institute of Science and Technology Graduate University, Okinawa 904-0495, Japan
  1. 7 These authors contributed equally to this work.

  • Corresponding author: rickie.patani{at}ucl.ac.uk
  • Abstract

    Astrocytes contribute to motor neuron death in amyotrophic lateral sclerosis (ALS), but whether they adopt deleterious features consistent with inflammatory reactive states remains incompletely resolved. To identify inflammatory reactive features in ALS human induced pluripotent stem cell (hiPSC)–derived astrocytes, we examined transcriptomics, proteomics, and glutamate uptake in VCP-mutant astrocytes. We complemented this by examining other ALS mutations and models using a systematic meta-analysis of all publicly-available ALS astrocyte sequencing data, which included hiPSC-derived astrocytes carrying SOD1, C9orf72, and FUS gene mutations as well as mouse ALS astrocyte models with SOD1G93A mutation, Tardbp deletion, and Tmem259 (also known as membralin) deletion. ALS astrocytes were characterized by up-regulation of genes involved in the extracellular matrix, endoplasmic reticulum stress, and the immune response and down-regulation of synaptic integrity, glutamate uptake, and other neuronal support processes. We identify activation of the TGFB, Wnt, and hypoxia signaling pathways in both hiPSC and mouse ALS astrocytes. ALS changes positively correlate with TNF, IL1A, and complement pathway component C1q-treated inflammatory reactive astrocytes, with significant overlap of differentially expressed genes. By contrasting ALS changes with models of protective reactive astrocytes, including middle cerebral artery occlusion and spinal cord injury, we uncover a cluster of genes changing in opposing directions, which may represent down-regulated homeostatic genes and up-regulated deleterious genes in ALS astrocytes. These observations indicate that ALS astrocytes augment inflammatory processes while concomitantly suppressing neuronal supporting mechanisms, thus resembling inflammatory reactive states and offering potential therapeutic targets.

    Footnotes

    • [Supplemental material is available for this article.]

    • Article published online before print. Article, supplemental material, and publication date are at https://www.genome.org/cgi/doi/10.1101/gr.275939.121.

    • Freely available online through the Genome Research Open Access option.

    • Received June 25, 2021.
    • Accepted October 27, 2021.

    This article, published in Genome Research, is available under a Creative Commons License (Attribution 4.0 International), as described at http://creativecommons.org/licenses/by/4.0/.

    | Table of Contents
    OPEN ACCESS ARTICLE

    Preprint Server